80 related articles for article (PubMed ID: 19541835)
1. Dissecting VHL-associated pathologies.
Metzen E; Brockmeier U
Blood; 2009 Jun; 113(25):6273-4. PubMed ID: 19541835
[No Abstract] [Full Text] [Related]
2. Identification of the Lipodepsipeptide MDN-0066, a Novel Inhibitor of VHL/HIF Pathway Produced by a New Pseudomonas Species.
Cautain B; de Pedro N; Schulz C; Pascual J; Sousa Tda S; Martin J; Pérez-Victoria I; Asensio F; González I; Bills GF; Reyes F; Genilloud O; Vicente F
PLoS One; 2015; 10(5):e0125221. PubMed ID: 26018559
[TBL] [Abstract][Full Text] [Related]
3. Allelic Deletion of VHL Gene Detected in Papillary Tumors of the Broad Ligament, Epididymis, and Retroperitoneum in von Hippel-Lindau Disease Patients.
Shen T; Zhuang Z; Gersell DJ; Tavassoli FA
Int J Surg Pathol; 2000 Jul; 8(3):207-212. PubMed ID: 11493991
[TBL] [Abstract][Full Text] [Related]
4. Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease.
Hong B; Ma K; Zhou J; Zhang J; Wang J; Liu S; Zhang Z; Cai L; Zhang N; Gong K
Front Genet; 2019; 10():867. PubMed ID: 31620170
[TBL] [Abstract][Full Text] [Related]
5. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study.
Kano H; Shuto T; Iwai Y; Sheehan J; Yamamoto M; McBride HL; Sato M; Serizawa T; Yomo S; Moriki A; Kohda Y; Young B; Suzuki S; Kenai H; Duma C; Kikuchi Y; Mathieu D; Akabane A; Nagano O; Kondziolka D; Lunsford LD
J Neurosurg; 2015 Jun; 122(6):1469-78. PubMed ID: 25816088
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic aspects of Von Hippel-Lindau (VHL) disease and criteria for DNA analysis in subjects at risk.
Hes FJ; Lips CJ; van der Luijt RB
Neth J Med; 2001 Nov; 59(5):235-43. PubMed ID: 11705643
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.
Wang H; Shepard MJ; Zhang C; Dong L; Walker D; Guedez L; Park S; Wang Y; Chen S; Pang Y; Zhang Q; Gao C; Wong WT; Wiley H; Pacak K; Chew EY; Zhuang Z; Chan CC
Cancer Res; 2018 Mar; 78(5):1266-1274. PubMed ID: 29301791
[TBL] [Abstract][Full Text] [Related]
10. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel VHL targets that are associated with the development of renal cell carcinoma.
Abdulrahman M; Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Wiesener MS; Richards FM; Johnson CM; Latif F; Maher ER
Oncogene; 2007 Mar; 26(11):1661-72. PubMed ID: 17001320
[TBL] [Abstract][Full Text] [Related]
13. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
[TBL] [Abstract][Full Text] [Related]
14. RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program.
Jinesh GG; Kamat AM
Cell Death Discov; 2017; 3():17023. PubMed ID: 28580172
[TBL] [Abstract][Full Text] [Related]
15. Clinical diagnosis, treatment and screening of the VHL gene in three von Hippel-Lindau disease pedigrees.
Lin G; Zhao Y; Zhang Z; Zhang H
Exp Ther Med; 2020 Aug; 20(2):1237-1244. PubMed ID: 32742360
[TBL] [Abstract][Full Text] [Related]
16. Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor.
Lolkema MP; Mans DA; Ulfman LH; Volpi S; Voest EE; Giles RH
Eur J Hum Genet; 2008 Jan; 16(1):73-8. PubMed ID: 17912253
[TBL] [Abstract][Full Text] [Related]
17. A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease.
Jia D; Tang B; Shi Y; Wang J; Sun Z; Chen Z; Zhang L; Xia K; Jiang H
J Clin Neurosci; 2013 Jun; 20(6):842-7. PubMed ID: 23632291
[TBL] [Abstract][Full Text] [Related]
18. Novel gene mutation in von Hippel-Lindau disease - a report of two cases.
Wang J; Cao W; Wang Z; Zhu H
BMC Med Genet; 2019 Dec; 20(1):194. PubMed ID: 31823746
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term Study.
Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SY; Roche-Losada O; Sánchez-Prieto R; Giménez-Bachs JM
Clin Genitourin Cancer; 2017 Dec; 15(6):e923-e933. PubMed ID: 28624320
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlations in VHL exon deletions.
McNeill A; Rattenberry E; Barber R; Killick P; MacDonald F; Maher ER
Am J Med Genet A; 2009 Oct; 149A(10):2147-51. PubMed ID: 19764026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]